Recombinant interferon alfa-2C versus polychemotherapy (VMCP) for treatment of multiple myeloma: a prospective randomized trial
- 1 September 1986
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 22 (9) , 1111-1116
- https://doi.org/10.1016/0277-5379(86)90015-5
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Phase II study of recombinant alpha-2 interferon in resistant multiple myeloma.Journal of Clinical Oncology, 1985
- Interactions of human leukocyte interferon with vinca alkaloids and other chemotherapeutic agents against human tumors in clonogenic assayCancer Chemotherapy and Pharmacology, 1983
- Clinical and immunological studies of human fibroblast interferonCancer Chemotherapy and Pharmacology, 1982
- TREATMENT OF LYMPHOID NEOPLASIAS WITH INTERFERON .1. HUMAN FIBROBLASTIC BETA-INTERFERON IN MALIGNANT GAMMOPATHIES - PHASE-II TRIAL1982
- Interferon therapy in multiple myeloma: Failure of human fibroblast interferon administration to affect the course of light chain diseaseEuropean Journal of Cancer and Clinical Oncology, 1981
- In vitro inhibitory effect of interferon on colony formation of myeloma stem cellsCancer Immunology, Immunotherapy, 1980
- Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant LymphomaAnnals of Internal Medicine, 1980
- INTERFERON THERAPY IN MYELOMATOSISThe Lancet, 1979
- Interferon Therapy in Multiple MyelomaActa Medica Scandinavica, 1979
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958